Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
PsyKey, Inc., Achieves Key Revenue Milestone With Purchase Order Of Its Functional Mushroom Products CARSON CITY, NV -- January 12, 2022 -- InvestorsHub...
PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A. to its Strategic Advisory Board CARSON CITY, NV -- June 2, 2021 -- InvestorsHub NewsWire...
PsyKey Inc. Completes Definitive Agreement with MycoVita to establish a Strategic Partnership focused on Research, Development and Commercialization of Mycology based...
PsyKey Inc Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development Las Vegas, Nevada, April 14...
PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board Las Vegas, NV -- March 29, 2021 -- InvestorsHub NewsWire...
CECORS, INC. SHAREHOLDER UPDATE Las Vegas, NV -- January 14, 2021 -- InvestorsHub NewsWire -- CECORS, INC. (OTC PINK: CEOS...
CeCors Inc. Preparing Final Stages of Launching CannMedLive App LAS VEGAS, NV -- June 10, 2019 -- InvestorsHub NewsWire -- CeCors, Inc. (OTC PINK: CEOS), a Company...
CeCors Inc. (OTCBB: CEOS) today announced its entry into the Carrier Ethernet Switch marketplace, with the world?s first 10 terabit backplane. Jim Fiedler, Chairman and CEO...
CeCors Inc. (OTCBB:CEOS) announced today that Mark Perkell has joined the organization as Vice President and General Counsel. In this capacity, Perkell will be responsible for...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
